Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H. Fuchs J, et al. Among authors: erttmann r. Klin Padiatr. 1999 Jul-Aug;211(4):305-9. doi: 10.1055/s-2008-1043805. Klin Padiatr. 1999. PMID: 10472567
Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
von Schweinitz D, Byrd DJ, Hecker H, Weinel P, Bode U, Bürger D, Erttmann R, Harms D, Mildenberger H. von Schweinitz D, et al. Among authors: erttmann r. Eur J Cancer. 1997 Jul;33(8):1243-9. doi: 10.1016/s0959-8049(97)00095-6. Eur J Cancer. 1997. PMID: 9301450 Clinical Trial.
Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86).
Winkler K, Bielack S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw C, Jürgens H, Ritter J, Kusnierz-Glaz C, Erttmann R, et al. Winkler K, et al. Among authors: erttmann r. Cancer. 1990 Oct 15;66(8):1703-10. doi: 10.1002/1097-0142(19901015)66:8<1703::aid-cncr2820660809>3.0.co;2-v. Cancer. 1990. PMID: 2208024 Clinical Trial.
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
Winkler K, Beron G, Kotz R, Salzer-Kuntschik M, Beck J, Beck W, Brandeis W, Ebell W, Erttmann R, Göbel U, Havers W, Henze G, Hinderfield L, Höcker P, Jobke A, Jürgens H, Kabisch H, Landbeck G, Preusser P, Prindull G, Ramach W, Ritter J, Sekera J, Treuner J, Wüst G. Winkler K, et al. Among authors: erttmann r. J Cancer Res Clin Oncol. 1983;106 Suppl:1-7. doi: 10.1007/BF00625042. J Cancer Res Clin Oncol. 1983. PMID: 6193123 Clinical Trial.
105 results